olivlawolivlaw

olivLaw · US equity research

e.l.f. Beauty, Inc. ELF

Perfumes, Cosmetics & Other Toilet Preparations · SIC 2844 · Vertical: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)

113.63USD+1.91% · 1 dayClose 04 Nov 2026

e.l.f. Beauty is a multi-brand cosmetics and skin care company, with brands such as e.l.f. Cosmetics, e.l.f. SKIN and rhode, sold mainly through mass retailers and online channels. The company reported net sales growth of 25% in fiscal 2026, and net sales rose 36% in the first quarter of fiscal 2027, in a context where tariffs and tariff refunds remain important factors.

The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).

At the close of 04 Nov 2026, e.l.f. Beauty, Inc. (ELF) stock was 113.63 USD (+1.91% on the day), with market capitalisation 6.7 bn USD, P/E 113.6 on diluted EPS of 1.00 USD over the last 12 months, dividend yield 1.58%, beta 1.56, 52-week range 49.57–117.83 USD. Latest reported quarter (Q1 2027): revenue of 479.4 m USD (+35.5% YoY), net income of 66.6 m USD (+99.9% YoY), diluted EPS 1.12 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
6.7 bn USD
shares as of 30 Jul 2026
P/E (TTM)
113.6
Diluted EPS TTM 1.00 · TTM to 30 Jun 2026
E/P (TTM)
0.88%
TTM to 30 Jun 2026
Dividend yield
1.58%
DPS 12m 1.79
Beta (2y)
1.56
Volatility (1y) 70%
52-week range
49.57117.83

Price history

Loading chart…

Technical reading

RSI (14)
59.1
strong (55–70)
Bollinger (20, 2)
106.87 – 117.56
in the upper half of the band · %B 0.63 · band width 9.5%
SMA 50 / 200
105.97 / 81.64
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
2.32 / 2.91
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+9.5%−1.1%+10.6 pp—
3 months+31.6%−0.5%+32.0 pp—
6 months+85.0%+4.4%+80.6 pp—
Year to date+49.4%+12.3%+37.1 pp—
1 year−3.9%+13.5%−17.5 pp+4.5%
3 years+18.2%+76.4%−58.2 pp−14.8%
5 years+262.7%+63.7%+199.0 pp—
Max drawdown (1y)
−57.9%
05 Nov 2025 → 05 Jun 2026
Max drawdown (5y)
−77.3%
27 Jun 2024 → 05 Jun 2026
Compound annual growth (5y)
+29.4%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q1 2027 · 30 Jun 2026

Revenue
479.4 m USD
+35.5% YoY
Net income
66.6 m USD
+99.9% YoY
Diluted EPS
1.12
+93.1% YoY
net / operating
13.9% / 21.4%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27
Revenue301.1 m355.3 m332.6 m353.7 m343.9 m489.5 m449.3 m479.4 m
Cost of revenue87.0 m102.0 m95.6 m109.2 m105.1 m142.0 m122.8 m80.5 m
Gross profit214.1 m253.3 m237.0 m244.5 m238.9 m347.5 m326.5 m398.8 m
SG&A186.1 m218.2 m192.7 m195.8 m231.1 m280.0 m319.1 m280.3 m
Operating income27.9 m35.1 m44.3 m48.7 m7.7 m67.5 m-50.3 m102.4 m
Depreciation & amortisation10.2 m ≈11.6 m ≈13.2 m13.2 m18.3 m ≈21.6 m ≈26.3 m26.1 m
Pre-tax income27.9 m26.3 m44.0 m51.1 m-4.0 m53.9 m-60.5 m94.3 m
Income tax8.9 m9.0 m15.8 m17.8 m-7.0 m14.5 m-11.2 m27.7 m
Net income19.0 m17.3 m28.3 m33.3 m3.0 m39.4 m-49.4 m66.6 m
Diluted EPS0.330.300.490.580.050.65-0.821.12
Operating cash flow11.2 m ≈-14.7 m ≈136.1 m27.2 m23.4 m ≈59.4 m ≈102.5 m111.7 m
Capex1.6 m ≈5.1 m ≈11.1 m7.1 m6.8 m ≈6.6 m ≈1.9 m1.4 m
Share repurchases—0 ≈50.0 m00 ≈50.0 m ≈050.0 m

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 91 percentile of its own 32-quarter history (min 22.7, median 64.2, max 229.0; quarters with earnings only).

Fiscal years

Fiscal year20182020202120222023202420252026
Revenue267.4 m282.9 m318.1 m392.2 m578.8 m1.0 bn1.3 bn1.6 bn
Revenue YoY−0.9%unavailable+12.5%+23.3%+47.6%+76.9%+28.3%+24.6%
Net income15.5 m17.9 m6.2 m21.8 m61.5 m127.7 m112.1 m26.3 m
Net income YoY−53.6%unavailable−65.2%+249.3%+182.6%+107.5%−12.2%−76.5%
Diluted EPS0.320.350.120.411.112.211.920.44
Diluted EPS YoY−52.9%unavailable−65.7%+241.7%+170.7%+99.1%−13.1%−77.1%
net %5.8%6.3%2.0%5.6%10.6%12.5%8.5%1.6%
Free cash flow46.7 m34.9 m23.0 m14.7 m100.2 m62.5 m115.3 m190.1 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2026 · 31 Mar 2026

Cash
289.7 m USD
Financial debt
871.7 m USD
Net debt
582.0 m USD
Equity
1.1 bn USD
Total assets
2.4 bn USD
Debt / equity
0.77x
Current ratio
2.35x
ROE
2.8%
ROA
1.4%
FCF margin
11.6%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2024
1.0 bn
2025
1.3 bn
2026
1.6 bn

SEC (XBRL)· 21 May 2026verified

Cost of revenue
2024
299.8 m
2025
377.8 m
2026
479.1 m

SEC (XBRL)· 21 May 2026verified

Gross profit
2024
724.1 m
2025
935.7 m
2026
1.2 bn

SEC (XBRL)· 21 May 2026verified

SG&A
2024
574.4 m
2025
777.7 m
2026
1.0 bn

SEC (XBRL)· 21 May 2026verified

Operating income
2024
149.7 m
2025
158.0 m
2026
73.6 m

SEC (XBRL)· 21 May 2026verified

Depreciation & amortisation
2024
30.2 m
2025
44.1 m
2026
79.4 m

SEC (XBRL)· 21 May 2026verified

EBITDA
2024
179.8 m ≈
2025
202.1 m ≈
2026
153.0 m ≈

SEC (XBRL)· 21 May 2026derived

Pre-tax income
2024
141.0 m
2025
145.5 m
2026
40.5 m

SEC (XBRL)· 21 May 2026verified

Income tax
2024
13.3 m
2025
33.4 m
2026
14.1 m

SEC (XBRL)· 21 May 2026verified

Net income
2024
127.7 m
2025
112.1 m
2026
26.3 m

SEC (XBRL)· 21 May 2026verified

Diluted EPS
2024
2.21
2025
1.92
2026
0.44

SEC (XBRL)· 21 May 2026verified

Weighted average diluted shares
2024
57.8 m
2025
58.3 m
2026
59.4 m

SEC (XBRL)· 21 May 2026verified

Balance sheet · USD

Cash
2024
108.2 m
2025
148.7 m
2026
289.7 m

SEC (XBRL)· 21 May 2026verified

Receivables
2024
123.8 m
2025
126.0 m
2026
174.6 m

SEC (XBRL)· 21 May 2026verified

Inventories
2024
191.5 m
2025
187.2 m
2026
220.2 m

SEC (XBRL)· 21 May 2026verified

Current assets
2024
477.1 m
2025
540.6 m
2026
789.4 m

SEC (XBRL)· 21 May 2026verified

Property, plant & equipment, net
2024
14.0 m
2025
28.8 m
2026
41.5 m

SEC (XBRL)· 21 May 2026verified

Goodwill
2024
340.6 m
2025
340.6 m
2026
853.5 m

SEC (XBRL)· 21 May 2026verified

Intangibles (excl. goodwill)
2024
225.1 m
2025
207.7 m
2026
553.1 m

SEC (XBRL)· 21 May 2026verified

Total assets
2024
1.1 bn
2025
1.2 bn
2026
2.4 bn

SEC (XBRL)· 21 May 2026verified

Accounts payable
2024
81.1 m
2025
72.2 m
2026
97.5 m

SEC (XBRL)· 21 May 2026verified

Short-term debt
2024
100.3 m
2025
0
2026
30.0 m

SEC (XBRL)· 21 May 2026verified

Long-term debt
2024
—
2025
—
2026
841.7 m

SEC (XBRL)· 21 May 2026verified

Current liabilities
2024
299.1 m
2025
177.1 m
2026
336.2 m

SEC (XBRL)· 21 May 2026verified

Total liabilities
2024
486.7 m
2025
487.3 m
2026
1.3 bn

SEC (XBRL)· 21 May 2026verified

Equity
2024
642.6 m †
2025
760.9 m †
2026
1.1 bn †

SEC (XBRL)· 21 May 2026verified

Cash flow · USD

Operating cash flow
2024
71.2 m
2025
133.8 m
2026
212.5 m

SEC (XBRL)· 21 May 2026verified

Capex
2024
8.7 m
2025
18.5 m
2026
22.4 m

SEC (XBRL)· 21 May 2026verified

Free cash flow
2024
62.5 m ≈
2025
115.3 m ≈
2026
190.1 m ≈

SEC (XBRL)· 21 May 2026derived

Investing cash flow
2024
-284.7 m
2025
-19.1 m
2026
-605.2 m

SEC (XBRL)· 21 May 2026verified

Financing cash flow
2024
200.9 m
2025
-74.4 m
2026
533.9 m

SEC (XBRL)· 21 May 2026verified

Share repurchases
2024
0
2025
67.1 m
2026
50.0 m

SEC (XBRL)· 21 May 2026verified

Computed indicators

Growth

Revenue growth (YoY)
24.6%
computed by olivLawFY 2026
Revenue CAGR 3Y
41.4%
computed by olivLawFY 2023 → FY 2026
Revenue CAGR 5Y
38.8%
computed by olivLawFY 2021 → FY 2026
EBIT growth (YoY)
-53.4%
computed by olivLawFY 2026
Net income growth (YoY)
-76.5%
computed by olivLawFY 2026
Net income CAGR 3Y
-24.7%
computed by olivLawFY 2023 → FY 2026
Net income CAGR 5Y
33.4%
computed by olivLawFY 2021 → FY 2026
EPS growth (YoY)
-77.1%
computed by olivLawFY 2026
EPS CAGR 3Y
-26.5%
computed by olivLawFY 2023 → FY 2026
EPS CAGR 5Y
29.7%
computed by olivLawFY 2021 → FY 2026
FCF growth (YoY)
64.8%
computed by olivLawFY 2026

Profitability

Gross margin
74.4%
computed by olivLawTTM to 30 Jun 2026
EBITDA margin
12.5%
computed by olivLawTTM to 30 Jun 2026
EBIT margin
7.2%
computed by olivLawTTM to 30 Jun 2026
Net margin
3.4%
computed by olivLawTTM to 30 Jun 2026
FCF margin
15.9%
computed by olivLawTTM to 30 Jun 2026

Returns

ROE
6.0%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROA
3.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROIC
7.8%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROCE
6.0%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
519.9 m USD
computed by olivLawbalance sheet at 30 Jun 2026
Net debt / EBITDA
2.4x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Debt / equity
0.7x
computed by olivLawbalance sheet at 30 Jun 2026
Interest coverage
unavailable
the reported interest expense is far older than the latest period (the filer changed its XBRL tag): a stale figure is not used

Liquidity

Current ratio
2.5x
computed by olivLawbalance sheet at 30 Jun 2026
Quick ratio
1.8x
computed by olivLawbalance sheet at 30 Jun 2026
Cash ratio
1.0x
computed by olivLawbalance sheet at 30 Jun 2026

Cash

Operating cash flow
296.9 m USD
computed by olivLawTTM to 30 Jun 2026
Capital expenditure
16.8 m USD
computed by olivLawTTM to 30 Jun 2026
Free cash flow
280.2 m USD
computed by olivLawTTM to 30 Jun 2026
FCF conversion
470.0%
computed by olivLawTTM to 30 Jun 2026
Cash conversion
135.2%
computed by olivLawTTM to 30 Jun 2026

Efficiency

Days sales outstanding
36 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Days inventory outstanding
169 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Days payables outstanding
69 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Cash conversion cycle
136 days
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

Market and valuation

Market capitalisation
6.7 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Enterprise value
7.2 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
Market cap / net income TTM
112.5x
computed by olivLawTTM to 30 Jun 2026
P/E (TTM)
113.6x
computed by olivLawTTM to 30 Jun 2026
Earnings yield
0.9%
computed by olivLawTTM to 30 Jun 2026
P/B
5.7x
computed by olivLawbalance sheet at 30 Jun 2026
P/S
3.8x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/EBITDA
32.9x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/EBIT
56.7x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
EV/Sales
4.1x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
P/FCF
23.9x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
FCF yield
4.2%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Dividend yield
1.6%
computed by olivLawTTM to 30 Jun 2026
Shareholder yield (distributions)
1.5%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Neutral profile

Score: 40 / 100

A scoring methodology on indicators and valuation, not investment advice.

Closing price

113.63 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 6.7 bn USD

Key indicators

Market capitalisation
6.7 bn USD
computed by olivLawbalance sheet at 30 Jun 2026
P/E (TTM)
113.6x
computed by olivLawTTM to 30 Jun 2026
P/B
5.7x
computed by olivLawbalance sheet at 30 Jun 2026
EV/EBITDA
32.9x
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
ROE
6.0%
computed by olivLawTTM to 30 Jun 2026 · balance sheet at 30 Jun 2026
Net margin
3.4%
computed by olivLawTTM to 30 Jun 2026
Revenue growth (YoY)
24.6%
computed by olivLawFY 2026
Dividend yield
1.6%
computed by olivLawTTM to 30 Jun 2026

Coverage and freshness

32/37 reporting lines present
Latest full fiscal year: 2026
Latest reported period: 30 Jun 2026
Latest balance sheet date: 30 Jun 2026
Share count (cover of the latest filing), as of: 30 Jul 2026
Source: SEC (XBRL)published 06 Aug 2026
verified 1718derived 111

Score by group

  • Valuation15
  • Returns21
  • Quality60
  • Balance sheet57
  • Growth50

Estimated value range

Low
23.52
USD per share
Mid
26.98
USD per share
High
31.63
USD per share
Price: 113.63 USD
The price is above the range
Potential to the central value: -76.3% (value / price − 1)
Margin of safety: -321.1% (1 − price / value)
Agreement between methods: low · 3 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 12.78 – 73.55 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · the reported interest expense is far older than the latest period (the filer changed its XBRL tag): a stale figure is not used
  • Peers: EV/EBITDA43.05 – 73.55 (Mid 59.90)
    4 companies used · median multiple 18.5x · quartiles 13.9x – 22.1x
    CL, COTY, EPC, KVUE
  • Peers: P/E12.78 – 21.90 (Mid 16.68)
    5 companies used · median multiple 16.7x · quartiles 12.8x – 21.9x
    AXIL, IPAR, KVUE, ODD, UG
  • Dividend discount (DDM)23.52 – 31.63 (Mid 26.98)
Multiple comparisons use the SIC vertical: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Neutral profile · Score 40/100

FactorValueScoreWeight used
ROIC · Quality7.8%40 (vs peers)12%
Net margin · Quality3.4%53 (vs peers)7%
FCF conversion · Quality470.0%100 (on a fixed band)7%
Revenue CAGR 3Y · Growth41.4%100 (on a fixed band)9%
EPS CAGR 3Y · Growth-26.5%0 (on a fixed band)9%
Net debt / EBITDA · Balance sheet2.4x40 (vs peers)12%
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheet2.5x100 (on a fixed band)5%
P/E (TTM) · Valuation113.6x0 (vs peers)12%
EV/EBITDA · Valuation32.9x0 (on a fixed band)12%
FCF yield · Valuation4.2%52 (on a fixed band)9%
Shareholder yield (distributions) · Returns1.5%21 (on a fixed band)7%
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet57/100 · 2/3 factors with a value
  • Growth50/100 · 2/2 factors with a value
  • Quality60/100 · 3/3 factors with a value
  • Returns· partial21/100 · 1/2 factors with a value
  • Valuation15/100 · 3/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

e.l.f. Beauty, Inc. (ELF). Latest full fiscal year: 2026; data up to 2026-06-30.

Figures computed from the financial statements: revenue 1.6 bn USD in 2026; YoY growth 24.6%; net margin 3.4%; ROE 6.0%; net debt/EBITDA 2.4x.

The estimated value range is 23.52–31.63 USD per share (median of 3 methods, agreement: low); assumptions are illustrative. Against the central value of 26.98 USD, the price of 113.63 USD leaves a potential of -76.3% (value / price − 1) and a margin of safety of -321.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

olivLaw score 40/100, methodological classification: neutral profile (score, margin of safety and method agreement together; not a judgement of the right price). Groups assessed only in part: returns. Not investment advice.

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • FCF conversion: 470.0%
  • Revenue CAGR 3Y: 41.4%
  • Current ratio: 2.5x

What contradicts it

  • EPS CAGR 3Y: -26.5%
  • P/E (TTM): 113.6x
  • EV/EBITDA: 32.9x
  • Shareholder yield (distributions): 1.5%
  • The price is above the estimated value range
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): Interest coverage, Payout ratio (FCF).

Versus the vertical median

Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844) · same industry (4-digit SIC) · compared with 15 companies

Multiples and returns vs the median

P/E
113.6x
vertical median 21.9x
above median (+418.9%)
EV/EBITDA
32.9x
vertical median 18.5x
above median (+78.2%)
P/S
3.8x
vertical median 2.4x
above median (+59.2%)
P/B
5.7x
vertical median 2.7x
above median (+108.9%)
ROE
6.0%
vertical median 9.3%
below median (−34.9%)
Net margin
3.4%
vertical median 2.4%
above median (+40.5%)
EBIT margin
7.2%
vertical median 8.3%
below median (−13.2%)
Revenue YoY
24.6%
vertical median 1.9%
above median (+1,164.3%)
Net debt/EBITDA
2.4x
vertical median 2.3x
at median
Dividend yield
1.6%
vertical median 2.6%
below median (−39.2%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
CLColgate-Palmolive Company78.5 bn38.7358.9%9.6%+1.4%+23% / +25%
KVUEKenvue Inc.37.1 bn21.916.3%10.9%−2.1%+34% / +4%
ELFe.l.f. Beauty, Inc.6.7 bn113.66.0%3.4%+24.6%−4% / +18%
IPARInterparfums, Inc.4.0 bn23.319.5%11.3%+2.5%+52% / −1%
COTYCoty Inc.3.1 bn—-18.5%-10.4%−1.5%+5% / −70%
EPCEdgewell Personal Care Company1.4 bn—-6.2%-4.2%−1.3%+66% / −15%
SLSNSolesence, Inc.64.6 m—-15.1%-3.8%+18.6%−60% / +22%
AXILAxil Brands, Inc.38.2 m16.723.3%9.3%+17.5%+10% / unavailable
UGUnited-Guardian, Inc.31.5 m12.821.4%22.0%−13.4%+18% / −16%
CABRCaring Brands, Inc.9.3 m—-3,889.1%-183,298.7%unavailable−13% / unavailable
BNKKBonk, Inc.9.3 m—-332.4%-2,330.4%+201.6%−82% / −99%
YCBDcbdMD, Inc.4.5 m—-40.3%-13.8%−1.5%−34% / −93%
HLNHaleon plc——10.2%15.1%−1.8%−6% / +8%
ODDOddity Tech Ltd—12.032.6%13.7%+25.2%−50% / −37%
ELEstee Lauder Companies Inc—111.79.3%2.4%+5.0%+19% / −12%
YSGYatsen Holding Limited——-2.7%-1.9%+32.2%−67% / −49%

1- and 3-year price returns: for ELF from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
75.01
Total return -34% · Per year -34%
132.00
Total return 16% · Per year 16%
198.00
Total return 74% · Per year 74%
3 years
88.97
Total return -22% · Per year -8%
174.57
Total return 54% · Per year 15%
285.12
Total return 151% · Per year 36%
5 years
105.53
Total return -7% · Per year -1%
230.87
Total return 103% · Per year 15%
410.57
Total return 261% · Per year 29%
What moves the 3-year price the most
  • Exit P/E± 43.64
  • Net margin± 30.55
  • Annual revenue growth± 22.78
  • Annual dilution± 2.57

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results).

In brief

e.l.f. Beauty is a multi-brand cosmetics and skin care company, with brands such as e.l.f. Cosmetics, e.l.f. SKIN and rhode, sold mainly through mass retailers and online channels. The company reported net sales growth of 25% in fiscal 2026 1, and net sales rose 36% in the first quarter of fiscal 2027 23, in a context where tariffs and tariff refunds remain important factors.

SWOT

Strengths

  • A brand portfolio with a clear accessible-price positioning and perceived premium quality, supported by innovations that have reached top positions in mass cosmetics 1.
  • A productivity and distribution model built on an own e-commerce channel and strong relationships with large retailers, with strong sales growth in the first quarter of fiscal 2027 12.
  • An internal culture and high employee engagement, which the company links to performance and to attracting talent 1.

Weaknesses

  • Brand awareness among consumers remains relatively low compared with established brands in the industry 1.
  • Dependence on a few large retailers and on manufacturers concentrated in China exposes the company to order changes and trade risks 1.
  • Sales growth has not fully translated into stable operating results, and marketing and distribution costs have risen considerably 12.

Opportunities

  • Expansion into adjacent categories and international markets could diversify revenue sources, if product launches succeed 1.
  • Integrating the rhode brand and other acquisitions could support growth in premium segments 12.
  • Digital channels and loyalty programs could raise purchase frequency if the company keeps its innovation pace 1.

Threats

  • Tariffs and changes in trade policy can raise costs or reduce access to products, with a direct effect on margins 12.
  • Large competitors with greater financial resources can respond with price cuts or aggressive promotions 1.
  • Risks related to product safety, regulation and brand reputation can quickly affect sales 1.
  • Rapid shifts in consumer trends can make existing or new products less attractive to buyers 1.

Risks

  • Customer concentrationhigh

    A small number of large retailers generates a major part of sales, and a change in their orders or strategy could affect quarterly results 1.

  • Tariffs and trade policyhigh

    Most products are made in China, and tariffs and trade retaliation could raise costs or interrupt supply 12.

  • Dependence on one acquisition's performancemedium

    The rhode acquisition includes contingent payments that depend on reaching revenue thresholds, which adds uncertainty to future reporting 13.

  • Competitive pressuremedium

    Larger competitors could cut prices or win shelf space, which could affect the company's volumes and margins 1.

  • Product safety and reputationmedium

    Quality, contamination or compliance problems could lead to product recalls and weaken consumer confidence 1.

Investment thesis

What would need to be true (bull case)

  • Sales growth has continued quarter after quarter, and the fiscal 2027 outlook was raised, which could support expansion above expectations if the trend holds 13.
  • The rhode brand and continued innovation across existing brands could strengthen the company's position in premium segments at accessible prices 1.
  • If tariff refunds and lower sourcing costs continue, margins could remain above historical levels 23.

What would break the thesis

  • Dependence on large retailers and on a single supply chain could lead to lost sales if they reduce orders or shelf space 1.
  • Part of the margin increase in the first quarter of fiscal 2027 came from tariff refunds, which are not recurring, so future results could be more modest 23.
  • Marketing and distribution costs have at times grown faster than sales, which could limit profitability if the trend continues 2.

What to watch

  • Gross margin trend excluding IEEPA tariff refund effectsQ2 2027
  • Pace of sales growth against the updated fiscal 2027 outlook2027
  • Tariff rates on products made in China and the outcome of the government's appeal of the court ordernext 10-K
  • Status of the rhode contingent payment and the brand's revenue indicators against earnout thresholdsQ2 2027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results).

The business

e.l.f. Beauty aims to offer premium beauty products at accessible prices, with vegan formulas, cruelty-free certification and, in many cases, manufacturing in Fair Trade Certified facilities 1. The portfolio includes e.l.f. Cosmetics, e.l.f. SKIN, rhode, Naturium and Well People, and in the first quarter of fiscal 2027 the company also began reporting the e.l.f. Hair brand 2. The business model is asset-light: products are made by third-party suppliers, mainly in China, and distributed through retailers and the company's own e-commerce channel 1. The rhode acquisition, completed in August 2025 for $897.5 million, significantly expanded the portfolio 1.

Sales are concentrated: Target, Walmart, Amazon and Sephora together accounted for 52% of net sales in fiscal 2026 1, which makes the company sensitive to these customers' shelf and order decisions. Sales are seasonal, with the highest levels in the third and fourth fiscal quarters, linked to the holiday season and shelf resets 1.

On recent performance, quarterly results show a clear gap between sales growth and operating margin: in the first quarter of fiscal 2027, gross margin rose sharply, but a significant part of this increase came from IEEPA tariff refunds 23. The company raised its fiscal 2027 outlook to 18-20% net sales growth 3.

Segments

National and international retailers

Retailers accounted for 76% of net sales in fiscal 2026, and sales through this channel grew 16% in the same year 1. Retailers are the main distribution route and access point to consumers.

E-commerce

The online channel accounted for 24% of net sales in fiscal 2026 and grew 63% in the same year 1. In the first quarter of fiscal 2027, e-commerce growth was even stronger, in part through the rhode acquisition 2.

International markets

Markets outside the United States accounted for 21% of net sales in fiscal 2026, mainly the UK, Canada and Germany 1. This component is smaller but relevant for geographic diversification.

Market context

The cosmetics industry is relatively concentrated, with a significant share of US retail sales generated by brands owned by a few large multinational companies 1. At the same time, independent brands keep entering the market with new and customized offers 1. For e.l.f. Beauty, the relevant market is mass cosmetics, where the average product price of e.l.f. Cosmetics in the US is about $7, compared with $10 for other leading mass brands and $30 for prestige brands 1.

Market dynamics are shaped by consumers' search for premium-quality products at accessible prices, and by the importance of social media and digital channels in promoting products 1. The company says it has gained ground in this direction, but brand awareness remains lower than that of established brands 1.

Trends

  • Tariffs and IEEPA refundsmixed

    Most products are made in China and were subject to high tariffs; after the Supreme Court ruling in February 2026, IEEPA tariffs paid are refundable, and in the first quarter of fiscal 2027 the company received refunds of about $51.1 million 12. The 10% global tariff applied since February 2026 remains in effect for most importers, which could affect future costs 2.

  • Growth of digital channelstailwind

    E-commerce sales grew strongly in fiscal 2026 and in the first quarter of fiscal 2027, indicating solid demand for the company's digital channel 12.

  • Concentration of large customersheadwind

    Reliance on a few large retailers can support volumes, but it means their shelf and order decisions have an outsized effect on results 1.

  • Pressure from marketing and distribution costsheadwind

    Selling, general and administrative expenses rose in the first quarter of fiscal 2027, mainly for marketing, merchandising and distribution, which could limit operating margin 2.

Competitive position

The company competes with multinational cosmetics groups that own several brands, have greater financial and marketing resources and occupy more shelf space 1. Competition is based on price, quality, innovation, in-store presence and promotional activity 1.

Besides the large groups, online, indie, celebrity- and influencer-backed brands frequently emerge and can quickly build consumer followings 1. Competitive pressure can force price cuts or lost sales, especially when competitors have greater resources 1.

  • Estee LauderEL

    Multinational cosmetics company owning several brands, competing with e.l.f. Beauty in make-up and skin care 1.

  • L'Oréal

    Multinational group with numerous cosmetics brands, named in the source among the dominant players in the industry 1.

  • CotyCOTY

    Cosmetics and fragrance company with several brands, named among major competitors in the industry 1.

  • Procter & GamblePG

    Consumer group with beauty and personal care brands, competing for shelf space in mass retail 1.

News & filings

In the press

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2026-03-31 · SEC / e.l.f. Beauty, Inc. · 21 May 2026
  2. [2] Form 10-Q, quarter ended 2026-06-30 · SEC / e.l.f. Beauty, Inc. · 06 Aug 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / e.l.f. Beauty, Inc. · 05 Aug 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.